Drugs / Bet v1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00410930 | Nov 2002 → Nov 2005 | allergic disease | Stallergenes Greer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bet v1 | “recombinant Bet v1” NCT00410930 ↗ |
| Modality | Protein / enzyme biologic | “recombinant Bet v1” NCT00410930 ↗ |
| Route | Subcutaneous | “used for subcutaneous immunotherapy” NCT00410930 ↗ |